Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits
J. Clin. Invest. Lea Scheppke, et al. 118:2337 doi:10.1172/JCI33361 [Go to this article.]

Figure 5
TG100572 inhibits FAK-Y861 phosphorylation during developmental angiogenesis. Choroid/sclera homogenate of BALB/c pups injected i.p. with TG100572 twice daily at the indicated doses.